{"paper_id":"278af840-1bc0-4d23-bda9-30b5504020f4","body_text":"Abstract\nAlthough the pathogenesis of endometriosis is not fully understood, it is often considered to be an inflammatory disease. An increasing number of studies suggest that differential expression of anti-inflammatory cytokines (e.g., interleukin-4 and -10, and transforming growth factor-β1) occurs in women with endometriosis, including in serum, peritoneal fluid and ectopic lesions. These anti-inflammatory cytokines also have indispensable roles in the progression of endometriosis, including by promoting survival, growth, invasion, differentiation, angiogenesis, and immune escape of the endometriotic lesions. In this review, we provide an overview of the expression, origin, function and regulation of anti-inflammatory cytokines in endometriosis, with brief discussion and perspectives on their future clinical implications in the diagnosis and therapy of the disease.\nSimilar content being viewed by others\nReferences\nGiudice L, Kao L (2004) Endometriosis. Lancet 364(9447):1789–1799. https://doi.org/10.1016/S0140-6736(04)17403-5\nCulley L, Law C, Hudson N et al (2013) The social and psychological impact of endometriosis on women’s lives: a critical narrative review. Hum Reprod Update 19(6):625–639. https://doi.org/10.1093/humupd/dmt027\nGuo SW (2009) Recurrence of endometriosis and its control. Hum Reprod Update 15(4):441–461. https://doi.org/10.1093/humupd/dmp007\nSimpson PD, McLaren JS, Rymer J et al (2015) Minimising menopausal side effects whilst treating endometriosis and fibroids. Post Reprod Health 21(1):16–23. https://doi.org/10.1177/2053369114568440\nSimoens S, Hummelshoj L, D’Hooghe T (2007) Endometriosis: cost estimates and methodological perspective. Hum Reprod Update 13(4):395–404. https://doi.org/10.1093/humupd/dmm010\nDe Graaff AA, D’Hooghe TM, Dunselman GA et al (2013) The significant effect of endometriosis on physical, mental and social wellbeing: results from an international crosssectional survey. Hum Reprod 28(10):2677–2685. https://doi.org/10.1093/humrep/det284\nMori H, Sawairi M, Nakagawa M et al (1991) Peritoneal fluid interleukin-1 beta and tumor necrosis factor in patients with benign gynecologic disease. Am J Reprod Immunol 26(2):62–67\nRier SE, Zarmakoupis PN, Hu X et al (1995) Dysregulation of interleukin-6 responses in ectopic endometrial stromal cells: correlation with decreased soluble receptor levels in peritoneal fluid of women with endometriosis. J Clin Endocrinol Metab 80(4):1431–1437. https://doi.org/10.1210/jcem.80.4.7714120\nHirata T, Osuga Y, Hamasaki K et al (2008) Interleukin (IL)-17A stimulates IL-8 secretion, cyclooxygensase-2 expression, and cell proliferation of endometriotic stromal cells. Endocrinology 149(3):1260–1267. https://doi.org/10.1210/en.2007-0749\nMilewski Ł, Barcz E, Dziunycz P et al (2008) Association of leptin with inflammatory cytokines and lymphocyte subpopulations in peritoneal fluid of patients with endometriosis. J Reprod Immunol 79(1):111–117. https://doi.org/10.1016/j.jri.2008.08.007\nCarmona F, Chapron C, Martinez-Zamora MA et al (2012) Ovarian endometrioma but not deep infiltrating endometriosis is associated with increased serum levels of interleukin-8 and interleukin-6. J Reprod Immunol 95(1–2):80–86. https://doi.org/10.1016/j.jri.2012.06.001\nAhn SH, Edwards AK, Singh SS et al (2015) IL-17A contributes to the pathogenesis of endometriosis by triggering proinflammatory cytokines and angiogenic growth factors. J Immunol 195(6):2591–2600. https://doi.org/10.4049/jimmunol.1501138\nLuisi S, Pinzauti S, Regini C et al (2015) Serum markers for the noninvasive diagnosis of endometriosis. Womens Health (Lond) 11(5):603–610. https://doi.org/10.2217/whe.15.46\nMalutan AM, Drugan T, Costin N et al (2015) Pro-inflammatory cytokines for evaluation of inflammatory status in endometriosis. Cent Eur J Immunol 40(1):96–102. https://doi.org/10.5114/ceji.2015.50840\nSikora J, Mielczarek-Palacz A, Kondera-Anasz Z et al (2015) Peripheral blood proinflammatory response in women during menstrual cycle and endometriosis. Cytokine 76(2):117–122. https://doi.org/10.1016/j.cyto.2015.08.007\nGogacz M, Winkler I, Bojarska-Junak A et al (2016) Increased percentage of Th17 cells in peritoneal fluid is associated with severity of endometriosis. J Reprod Immunol 117:39–44. https://doi.org/10.1016/j.jri.2016.04.289\nChristodoulakos G, Augoulea A, Lambrinoudaki I et al (2007) Pathogenesis of endometriosis: the role of defective ‘immunosurveillance’. Eur J Contracept Reprod Health Care 12(3):194–202. https://doi.org/10.1080/13625180701387266\nJiang L, Yan Y, Liu Z et al (2016) Inflammation and endometriosis. Front Biosci (Landmark Ed) 21:941–948\nRiccio LDGC, Santulli P, Marcellin L et al (2018) Immunology of endometriosis. Best Pract Res Clin Obstet Gynaecol 50:39–49. https://doi.org/10.1016/j.bpobgyn.2018.01.010\nMartínez S, Garrido N, Coperias JL et al (2007) Serum interleukin-6 levels are elevated in women with minimal-mild endometriosis. Hum Reprod 22(3):836–842. https://doi.org/10.1093/humrep/del419\nMay KE, Conduit-Hulbert SA, Villar J et al (2010) Peripheral biomarkers of endometriosis: a systematic review. Hum Reprod Update 16(6):651–674. https://doi.org/10.1093/humupd/dmq009\nMihalyi A, Gevaert O, Kyama CM et al (2010) Non-invasive diagnosis of endometriosis based on a combined analysis of six plasma biomarkers. Hum Reprod 25(3):654–664. https://doi.org/10.1093/humrep/dep425\nFalconer H, Mwenda JM, Chai DC et al (2006) Treatment with anti-TNF monoclonal antibody (c5N) reduces the extent of induced endometriosis in the baboon. Hum Reprod 21(7):1856–1862. https://doi.org/10.1093/humrep/del044\nAltintas D, Kokcu A, Tosun M et al (2008) Efficacy of recombinant human interferon alpha-2b on experimental endometriosis. Eur J Obstet Gynecol Reprod Biol 139(1):95–99. https://doi.org/10.1016/j.ejogrb.2007.09.006\nJerzak M, Niemiec T, Nowakowska A et al (2010) First successful pregnancy after addition of enoxaparin to sildenafil and etanercept immunotherapy in woman with fifteen failed IVF cycles—case report. Am J Reprod Immunol 64(2):93–96. https://doi.org/10.1111/j.1600-0897.2010.00826.x\nIslimye M, Kilic S, Zulfikaroglu E et al (2011) Regression of endometrial autografts in a rat model of endometriosis treated with etanercept. Eur J Obstet Gynecol Reprod Biol 159(1):184–189. https://doi.org/10.1016/j.ejogrb.2011.06.029\nZulfikaroglu E, Kılıc S, Islimye M et al (2011) Efficacy of anti-tumor necrosis factor therapy on endometriosis in an experimental rat model. Arch Gynecol Obstet 283(4):799–804. https://doi.org/10.1007/s00404-010-1434-0\nSoares SR, Martínez-Varea A, Hidalgo-Mora JJ et al (2012) Pharmacologic therapies in endometriosis: a systematic review. Fertil Steril 98(3):529–555. https://doi.org/10.1016/j.fertnstert.2012.07.1120\nLiu Y, Sun L, Hou Z et al (2016) rhTNFR: Fc suppresses the development of endometriosis in a mouse model by downregulating cell proliferation and invasiveness. Reprod Sci 23(7):847–857. https://doi.org/10.1177/1933719115620495\nKoninckx PR, Craessaerts M, Timmerman D et al (2008) Anti-TNF-alpha treatment for deep endometriosis-associated pain: a randomized placebo-controlled trial. Hum Reprod 23(9):2017–2023. https://doi.org/10.1093/humrep/den177\nLu D, Song H, Shi G (2013) Anti-TNF-α treatment for pelvic pain associated with endometriosis. Cochrane Database Syst Rev 28(3):CD008088. https://doi.org/10.1002/14651858.CD008088.pub3\nAhn SH, Singh V, Tayade C (2017) Biomarkers in endometriosis: challenges and opportunities. Fertil Steril 107(3):523–532. https://doi.org/10.1016/j.fertnstert.2017.01.009\nRocha AL, Vieira EL, Maia LM et al (2016) Prospective evaluation of a panel of plasma cytokines and chemokines as potential markers of pelvic endometriosis in symptomatic women. Gynecol Obstet Investig 81(6):512–517. https://doi.org/10.1159/000443956\nOpal SM, DePalo VA (2000) Anti-inflammatory cytokines. Chest 117(4):1162–1172\nPunnonen J, Teisala K, Ranta H et al (1996) Increased levels of interleukin-6 and interleukin-10 in the peritoneal fluid of patients with endometriosis. Am J Obstet Gynecol 174(5):1522–1526\nHo HN, Wu MY, Chao KH et al (1997) Peritoneal interleukin-10 increases with decrease in activated CD4+ T lymphocytes in women with endometriosis. Hum Reprod 12(11):2528–2533\nHsu CC, Yang BC, Wu MH et al (1997) Enhanced interleukin-4 expression in patients with endometriosis. Fertil Steril 67(6):1059–1064\nAntsiferova YS, Sotnikova NY, Posiseeva LV et al (2005) Changes in the T-helper cytokine profile and in lymphocyte activation at the systemic and local levels in women with endometriosis. Fertil Steril 84(6):1705–1711. https://doi.org/10.1016/j.fertnstert.2005.05.066\nPodgaec S, Abrao MS, Dias JA Jr et al (2007) Endometriosis: an inflammatory disease with a Th2 immune response component. Hum Reprod 22(5):1373–1379. https://doi.org/10.1093/humrep/del516\nMaluţan AM, Drugan T, Ciortea R et al (2015) Serum anti-inflammatory cytokines for the evaluation of inflammatory status in endometriosis. J Res Med Sci 20(7):668–674. https://doi.org/10.4103/1735-1995.166215\nMalutan AM, Drugan C, Drugan T et al (2016) The association between interleukin-4 -590C/T genetic polymorphism, IL-4 serum level, and advanced endometriosis. Cent Eur J Immunol 41(2):176–181. https://doi.org/10.5114/ceji.2016.60992\nSuen JL, Chang Y, Chiu PR et al (2014) Serum level of IL-10 is increased in patients with endometriosis, and IL-10 promotes the growth of lesions in a murine model. Am J Pathol 184(2):464–471. https://doi.org/10.1016/j.ajpath.2013.10.023\nMalutan AM, Drugan C, Walch K et al (2017) The association between interleukin-10 (IL-10) -592C/A, -819T/C, -1082G/A promoter polymorphisms and endometriosis. Arch Gynecol Obstet 295(2):503–510. https://doi.org/10.1007/s00404-016-4269-5\nFan YY, Chen HY, Chen W et al (2018) Expression of inflammatory cytokines in serum and peritoneal fluid from patients with different stages of endometriosis. Gynecol Endocrinol 34(6):507–512. https://doi.org/10.1080/09513590.2017.1409717\nGueuvoghlanian-Silva BY, Bellelis P, Barbeiro DF et al (2018) Treg and NK cells related cytokines are associated with deep rectosigmoid endometriosis and clinical symptoms related to the disease. J Reprod Immunol 126:32–38. https://doi.org/10.1016/j.jri.2018.02.003\nSikora J, Smycz-Kubańska M, Mielczarek-Palacz A et al (2018) The involvement of multifunctional TGF-β and related cytokines in pathogenesis of endometriosis. Immunol Lett 201:31–37. https://doi.org/10.1016/j.imlet.2018.10.011\nDrosdzol-Cop A, Skrzypulec-Plinta V, Stojko R (2012) Serum and peritoneal fluid immunological markers in adolescent girls with chronic pelvic pain. Obstet Gynecol Surv 67(6):374–381. https://doi.org/10.1097/OGX.0b013e31825cb12b\nChang KK, Liu LB, Jin LP et al (2017) IL-27 triggers IL-10 production in Th17 cells via a c-Maf/RORγt/Blimp-1 signal to promote the progression of endometriosis. Cell Death Dis 8(3):e2666. https://doi.org/10.1038/cddis.2017.95\nMier-Cabrera J, Jiménez-Zamudio L, García-Latorre E et al (2011) Quantitative and qualitative peritoneal immune profiles, T-cell apoptosis and oxidative stress-associated characteristics in women with minimal and mild endometriosis. BJOG 118(1):6–16. https://doi.org/10.1111/j.1471-0528.2010.02777.x\nTabibzadeh S, Becker JL, Parsons AK (2003) Endometriosis is associated with alterations in the relative abundance of proteins and IL-10 in the peritoneal fluid. Front Biosci 8:a70–a78\nZhang X, Hei P, Deng L et al (2007) Interleukin-10 gene promoter polymorphisms and their protein production in peritoneal fluid in patients with endometriosis. Mol Hum Reprod 13(2):135–140. https://doi.org/10.1093/molehr/gal106\nPodgaec S, Dias Junior JA, Chapron C et al (2010) Th1 and Th2 ummune responses related to pelvic endometriosis. Rev Assoc Med Bras (1992) 56(1):92–98\nWickiewicz D, Chrobak A, Gmyrek GB et al (2013) Diagnostic accuracy of interleukin-6 levels in peritoneal fluid for detection of endometriosis. Arch Gynecol Obstet 288(4):805–814. https://doi.org/10.1007/s00404-013-2828-6\nLi MQ, Wang Y, Chang KK et al (2014) CD4+Foxp3+ regulatory T cell differentiation mediated by endometrial stromal cell-derived TECK promotes the growth and invasion of endometriotic lesions. Cell Death Dis 5:e1436. https://doi.org/10.1038/cddis.2014.414\nJaeger-Lansky A, Schmidthaler K, Kuessel L et al (2018) Local and systemic levels of cytokines and danger signals in endometriosis-affected women. J Reprod Immunol 130:7–10. https://doi.org/10.1016/j.jri.2018.07.006\nHassa H, Tanir HM, Tekin B et al (2009) Cytokine and immune cell levels in peritoneal fluid and peripheral blood of women with early- and late-staged endometriosis. Arch Gynecol Obstet 279(6):891–895. https://doi.org/10.1007/s00404-008-0844-8\nAndreoli CG, Genro VK, Souza CA et al (2011) T helper (Th)1, Th2, and Th17 interleukin pathways in infertile patients with minimal/mild endometriosis. Fertil Steril 95(8):2477–2480. https://doi.org/10.1016/j.fertnstert.2011.02.019\nJiang J, Jiang Z, Xue M (2019) Serum and peritoneal fluid levels of interleukin-6 and interleukin-37 as biomarkers for endometriosis. Gynecol Endocrinol 11:1–5. https://doi.org/10.1080/09513590.2018.1554034\nXie J, Wang S, He B et al (2009) Association of estrogen receptor alpha and interleukin-10 gene polymorphisms with endometriosis in a Chinese population. Fertil Steril 92(1):54–60. https://doi.org/10.1016/j.fertnstert.2008.04.069\nWynn TA (2003) IL-13 effector functions. Annu Rev Immunol 21:425–456. https://doi.org/10.1146/annurev.immunol.21.120601.141142\nChegini N, Roberts M, Ripps B (2003) Differential expression of interleukins (IL)-13 and IL-15 in ectopic and eutopic endometrium of women with endometriosis and normal fertile women. Am J Reprod Immunol 49(2):75–83\nLee YH, Cui L, Fang J et al (2016) Limited value of pro-inflammatory oxylipins and cytokines as circulating biomarkers in endometriosis—a targeted ‘omics study. Sci Rep 6:26117. https://doi.org/10.1038/srep26117\nJørgensen H, Hill AS, Beste MT et al (2017) Peritoneal fluid cytokines related to endometriosis in patients evaluated for infertility. Fertil Steril 107(5):1191. https://doi.org/10.1016/j.fertnstert.2017.03.013\nHan G, Li F, Singh TP et al (2012) The pro-inflammatory role of TGFβ1: a paradox? Int J Biol Sci 8(2):228–235\nShull MM, Ormsby I, Kier AB et al (1992) Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 359(6397):693–699. https://doi.org/10.1038/359693a0\nLi MO, Wan YY, Sanjabi S et al (2006) Transforming growth factor-β regulation of immune responses. Annu Rev Immunol 24:99–146. https://doi.org/10.1146/annurev.immunol.24.021605.090737\nLee HJ, Kim H, Ku SY et al (2011) Transforming growth factor-β1 gene polymorphisms in Korean women with endometriosis. Am J Reprod Immunol 66(5):428–434. https://doi.org/10.1111/j.1600-0897.2011.01009.x\nKomiyama S, Aoki D, Komiyama M et al (2007) Local activation of TGF-beta1 at endometriosis sites. J Reprod Med 52(4):306–312\nMeng Q, Sun W, Jiang J et al (2011) Identification of common mechanisms between endometriosis and ovarian cancer. J Assist Reprod Genet 28(10):917–923. https://doi.org/10.1007/s10815-011-9573-1\nYu YX, Xiu YL, Chen X et al (2017) Transforming growth factor-beta 1 involved in the pathogenesis of endometriosis through regulating expression of vascular endothelial growth factor under hypoxia. Chin Med J (Engl) 130(8):950–956. https://doi.org/10.4103/0366-6999.204112\nShi LB, Zhou F, Zhu HY et al (2017) Transforming growth factor beta1 from endometriomas promotes fibrosis in surrounding ovarian tissues via Smad2/3 signaling. Biol Reprod 97(6):873–882. https://doi.org/10.1093/biolre/iox140\nChoi HJ, Park MJ, Kim BS et al (2017) Transforming growth factor β1 enhances adhesion of endometrial cells to mesothelium by regulating integrin expression. BMB Rep 50(8):429–434\nCai X, Shen M, Liu X et al (2018) Reduced expression of eukaryotic translation initiation factor 3 subunit e and its possible involvement in the epithelial-mesenchymal transition in endometriosis. Reprod Sci 25(1):102–109. https://doi.org/10.1177/1933719117702248\nPodgaec S, Rizzo LV, Fernandes LF et al (2012) CD4(+) CD25(high) Foxp3(+) cells increased in the peritoneal fluid of patients with endometriosis. Am J Reprod Immunol 68(4):301–308. https://doi.org/10.1111/j.1600-0897.2012.01173.x\nYoung VJ, Brown JK, Maybin J et al (2014) Transforming growth factor-β induced Warburg-like metabolic reprogramming may underpin the development of peritoneal endometriosis. J Clin Endocrinol Metab 99(9):3450–3459. https://doi.org/10.1210/jc.2014-1026\nYoung VJ, Brown JK, Saunders PT et al (2014) The peritoneum is both a source and target of TGF-β in women with endometriosis. PLoS One 9(9):e106773. https://doi.org/10.1371/journal.pone.0106773\nHanada T, Tsuji S, Nakayama M et al (2018) Suppressive regulatory T cells and latent transforming growth factor-β-expressing macrophages are altered in the peritoneal fluid of patients with endometriosis. Reprod Biol Endocrinol 16(1):9. https://doi.org/10.1186/s12958-018-0325-2\nKaiko GE, Phipps S, Angkasekwinai P et al (2010) NK cell deficiency predisposes to viral-induced Th2-type allergic inflammation via epithelial-derived IL-25. J Immunol 185(8):4681–4690. https://doi.org/10.4049/jimmunol.1001758\nGregory LG, Mathie SA, Walker SA et al (2010) Overexpression of Smad2 drives house dust mite-mediated airway remodeling and airway hyperresponsiveness via activin and IL-25. Am J Respir Crit Care Med 182(2):143–154. https://doi.org/10.1164/rccm.200905-0725OC\nZhang Y, Wang Y, Li MQ et al (2018) IL-25 promotes Th2 bias by upregulating IL-4 and IL-10 expression of decidual γδT cells in early pregnancy. Exp Ther Med 15(2):1855–1862. https://doi.org/10.3892/etm.2017.5638\nRank MA, Kobayashi T, Kozaki H et al (2009) IL-33-activated dendritic cells induce an atypical TH2-type response. J Allergy Clin Immunol 123(5):1047–1054. https://doi.org/10.1016/j.jaci.2009.02.026\nHu WT, Huang LL, Li MQ et al (2015) Decidual stromal cell-derived IL-33 contributes to Th2 bias and inhibits decidual NK cell cytotoxicity through NF-κB signaling in human early pregnancy. J Reprod Immunol 109:52–65. https://doi.org/10.1016/j.jri.2015.01.004\nGuo PF, Du MR, Wu HX et al (2010) Thymic stromal lymphopoietin from trophoblasts induces dendritic cell-mediated regulatory TH2 bias in the decidua during early gestation in humans. Blood 16(12):2061–2069. https://doi.org/10.1182/blood-2009-11-252940\nXie F, Liu LB, Shang WQ et al (2015) The infiltration and functional regulation of eosinophils induced by TSLP promote the proliferation of cervical cancer cell. Cancer Lett 364(2):106–117. https://doi.org/10.1016/j.canlet.2015.04.029\nPattarini L, Trichot C, Bogiatzi S et al (2017) TSLP-activated dendritic cells induce human T follicular helper cell differentiation through OX40-ligand. J Exp Med 214(5):1529–1546. https://doi.org/10.1084/jem.20150402\nOchiai S, Jagot F, Kyle RL et al (2018) Thymic stromal lymphopoietin drives the development of IL-13+ Th2 cells. Proc Natl Acad Sci USA 115(5):1033–1038. https://doi.org/10.1073/pnas.1714348115\nSaenz SA, Siracusa MC, Perrigoue JG et al (2010) IL25 elicits a multipotent progenitor cell population that promotes T(H)2 cytokine responses. Nature 464(7293):1362–1366. https://doi.org/10.1038/nature08901\nMjösberg JM, Trifari S, Crellin NK et al (2011) Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161. Nat Immunol 12(11):1055–1062. https://doi.org/10.1038/ni.2104\nHan M, Rajput C, Hong JY et al (2017) The innate cytokines IL-25, IL-33, and TSLP cooperate in the induction of type 2 innate lymphoid cell expansion and mucous metaplasia in rhinovirus-infected immature mice. J Immunol 199(4):1308–1318. https://doi.org/10.4049/jimmunol.1700216\nHalim TY, Krauss RH, Sun AC et al (2012) Lung natural helper cells are a critical source of Th2 cell-type cytokines in protease allergen-induced airway inflammation. Immunity 36(3):451–463. https://doi.org/10.1016/j.immuni.2011.12.020\nMatalliotakis I, Cakmak H, Matalliotakis M et al (2012) High rate of allergies among women with endometriosis. J Obstet Gynaecol 32(3):291–293. https://doi.org/10.3109/01443615.2011.644358\nBungum HF, Vestergaard C, Knudsen UB (2014) Endometriosis and type 1 allergies/immediate type hypersensitivity: a systematic review. Eur J Obstet Gynecol Reprod Biol 179:209–215. https://doi.org/10.1016/j.ejogrb.2014.04.025\nSantulli P, Borghese B, Chouzenoux S et al (2012) Serum and peritoneal interleukin-33 levels are elevated in deeply infiltrating endometriosis. Hum Reprod 27(7):2001–2009. https://doi.org/10.1093/humrep/des154\nUrata Y, Osuga Y, Izumi G et al (2012) Interleukin-1β stimulates the secretion of thymic stromal lymphopoietin (TSLP) from endometrioma stromal cells: possible involvement of TSLP in endometriosis. Hum Reprod 27(10):3028–3035. https://doi.org/10.1093/humrep/des291\nMbarik M, Kaabachi W, Henidi B et al (2015) Soluble ST2 and IL-33: Potential markers of endometriosis in the Tunisian population. Immunol Lett 166(1):1–5. https://doi.org/10.1016/j.imlet.2015.05.002\nMiller JE, Monsanto SP, Ahn SH et al (2017) Interleukin-33 modulates inflammation in endometriosis. Sci Rep 7(1):17903. https://doi.org/10.1038/s41598-017-18224-x\nBungum HF, Nygaard U, Vestergaard C et al (2016) Increased IL-25 levels in the peritoneal fluid of patients with endometriosis. J Reprod Immunol 114:6–9. https://doi.org/10.1016/j.jri.2016.01.003\nKondera-Anasz Z, Sikora J, Mielczarek-Palacz A et al (2005) Concentrations of interleukin (IL)-1alpha, IL-1 soluble receptor type II (IL-1 sRII) and IL-1 receptor antagonist (IL-1 Ra) in the peritoneal fluid and serum of infertile women with endometriosis. Eur J Obstet Gynecol Reprod Biol 123(2):198–203. https://doi.org/10.1016/j.ejogrb.2005.04.019\nZhang X, Wen J, Deng L et al (2007) Decreased levels of peritoneal interleukin-1 receptor antagonist in patients with endometriosis and disease-related dysmenorrhea. Fertil Steril 88(3):594–599. https://doi.org/10.1016/j.fertnstert.2006.11.155\nNold MF, Nold-Petry CA, Zepp JA et al (2010) IL-37 is a fundamental inhibitor of innate immunity. Nat Immunol 11(11):1014–1022. https://doi.org/10.1038/ni.1944\nBulau AM, Nold MF, Li S, Nold-Petry CA et al (2014) Role of caspase-1 in nuclear translocation of IL-37, release of the cytokine, and IL-37 inhibition of innate immune responses. Proc Natl Acad Sci USA 111(7):2650–2655. https://doi.org/10.1073/pnas.1324140111\nXie Y, Li Y, Cai X et al (2016) Interleukin-37 suppresses ICAM-1 expression in parallel with NF-κB down-regulation following TLR2 activation of human coronary artery endothelial cells. Int Immunopharmacol 38:26–30. https://doi.org/10.1016/j.intimp.2016.05.003\nJiang JF, Deng Y, Xue W et al (2016) Increased expression of interleukin 37 in the eutopic and ectopic endometrium of patients with ovarian endometriosis. Reprod Sci 23(2):244–248. https://doi.org/10.1177/1933719115602775\nKaabachi W, Kacem O, Belhaj R et al (2017) Interleukin-37 in endometriosis. Immunol Lett 185:52–55. https://doi.org/10.1016/j.imlet.2017.03.012\nPizzo A, Salmeri FM, Ardita FV et al (2002) Behaviour of cytokine levels in serum and peritoneal fluid of women with endometriosis. Gynecol Obstet Investig 54(2):82–87. https://doi.org/10.1159/000067717\nLaganà AS, Vitale SG, Salmeri FM et al (2017) Unus pro omnibus, omnes pro uno: a novel, evidence-based, unifying theory for the pathogenesis of endometriosis. Med Hypotheses 103:10–20. https://doi.org/10.1016/j.mehy.2017.03.032\nPaul Dmowski W, Braun DP (2004) Immunology of endometriosis. Best Pract Res Clin Obstet Gynaecol 18(2):245–263. https://doi.org/10.1016/j.bpobgyn.2004.02.001\nBos PD, Plitas G, Rudra D et al (2013) Transient regulatory T cell ablation deters oncogene-driven breast cancer and enhances radiotherapy. J Exp Med 210(11):2435–2466. https://doi.org/10.1084/jem.20130762\nQiao YC, Pan YH, Ling W et al (2017) The Yin and Yang of regulatory T cell and therapy progress in autoimmune disease. Autoimmun Rev 16(10):1058–1070. https://doi.org/10.1016/j.autrev.2017.08.001\nPereira LMS, Gomes STM, Ishak R et al (2017) Regulatory T cell and forkhead box protein 3 as modulators of immune homeostasis. Front Immunol 8:605. https://doi.org/10.3389/fimmu.2017.00605\nBasta P, Majka M, Jozwicki W et al (2010) The frequency of CD25+CD4+ and FOXP3+ regulatory T cells in ectopic endometrium and ectopic decidua. Reprod Biol Endocrinol 8:116. https://doi.org/10.1186/1477-7827-8-116\nOlkowska-Truchanowicz J, Bocian K, Maksym RB et al (2013) CD4+ CD25+ FOXP3+ regulatory T cells in peripheral blood and peritoneal fluid of patients with endometriosis. Hum Reprod 28(1):119–124. https://doi.org/10.1093/humrep/des346\nWei C, Mei J, Tang L et al (2016) 1-Methyl-tryptophan attenuates regulatory T cells differentiation due to the inhibition of estrogen-IDO1-MRC2 axis in endometriosis. Cell Death Dis 7(12):e2489. https://doi.org/10.1038/cddis.2016.375\nGazvani R, Templeton A (2002) Peritoneal environment, cytokines and angiogenesis in the pathophysiology of endometriosis. Reproduction 123(2):217–226\nOral E, Olive DL, Arici A (1996) The peritoneal environment in endometriosis. Hum Reprod Update 2(5):385–398\nWu MY, Ho HN, Chen SU et al (1999) Increase in the production of interleukin-6, interleukin-10, and interleukin-12 by lipopolysaccharide-stimulated peritoneal macrophages from women with endometriosis. Am J Reprod Immunol 41(1):106–111\nWang XQ, Yu J, Luo XZ et al (2010) The high level of RANTES in the ectopic milieu recruits macrophages and induces their tolerance in progression of endometriosis. J Mol Endocrinol 45(5):291–299. https://doi.org/10.1677/JME-09-0177\nMei J, Xie XX, Li MQ et al (2014) Indoleamine 2,3-dioxygenase-1 (IDO1) in human endometrial stromal cells induces macrophage tolerance through interleukin-33 in the progression of endometriosis. Int J Clin Exp Pathol 7(6):2743–2757\nYang HL, Zhou WJ, Chang KK et al (2017) The crosstalk between endometrial stromal cells and macrophages impairs cytotoxicity of NK cells in endometriosis by secreting IL-10 and TGF-β. Reproduction 154(6):815–825. https://doi.org/10.1530/REP-17-0342\nWang XQ, Zhou WJ, Luo XZ et al (2017) Synergistic effect of regulatory T cells and proinflammatory cytokines in angiogenesis in the endometriotic milieu. Hum Reprod 32(6):1304–1317. https://doi.org/10.1093/humrep/dex067\nSugamata M, Ihara T, Uchiide I (2005) Increase of activated mast cells in human endometriosis. Am J Reprod Immunol 53(3):120–125. https://doi.org/10.1111/j.1600-0897.2005.00254.x\nBerbic M, Fraser IS (2011) Regulatory T cells and other leukocytes in the pathogenesis of endometriosis. J Reprod Immunol 88(2):149–155. https://doi.org/10.1016/j.jri.2010.11.004\nMenzies FM, Shepherd MC, Nibbs RJ et al (2011) The role of mast cells and their mediators in reproduction, pregnancy and labour. Hum Reprod Update 17(3):383–396. https://doi.org/10.1093/humupd/dmq053\nMariuzzi L, Domenis R, Orsaria M et al (2016) Functional expression of aryl hydrocarbon receptor on mast cells populating human endometriotic tissues. Lab Investig 96(9):959–971. https://doi.org/10.1038/labinvest.2016.74\nGabrilovich DI, Nagaraj S (2009) Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 9(3):162–174. https://doi.org/10.1038/nri2506\nGabrilovich D (2004) Mechanisms and functional significance of tumour-induced dendritic-cell defects. Nat Rev Immunol 4(12):941–952. https://doi.org/10.1038/nri1498\nChen H, Qin S, Lei A et al (2017) Expansion of monocytic myeloid-derived suppressor cells in endometriosis patients: a pilot study. Int Immunopharmacol 47:150–158. https://doi.org/10.1016/j.intimp.2017.03.026\nZhang T, Zhou J, Man GCW et al (2018) MDSCs drive the process of endometriosis by enhancing angiogenesis and are a new potential therapeutic target. Eur J Immunol 48(6):1059–1073. https://doi.org/10.1002/eji.201747417\nSun Y, Shao J, Jiang F et al (2018) CD33+ CD14+ CD11b+ HLA-DR− monocytic myeloid-derived suppressor cells recruited and activated by CCR9/CCL25 are crucial for the pathogenic progression of endometriosis. Am J Reprod Immunol 30:e13067. https://doi.org/10.1111/aji.13067\nChen Y, Wang K, Xu Y et al (2018) Alteration of myeloid-derived suppressor cells, chronic inflammatory cytokines, and exosomal miRNA contribute to the peritoneal immune disorder of patients with endometriosis. Reprod Sci 19:1933719118808923. https://doi.org/10.1177/1933719118808923\nOuyang Z, Osuga Y, Hirota Y et al (2010) Interleukin-4 induces expression of eotaxin in endometriotic stromal cells. Fertil Steril 94(1):58–62. https://doi.org/10.1016/j.fertnstert.2009.01.129\nSui C, Mecha E, Omwandho CO et al (2016) PAI-1 secretion of endometrial and endometriotic cells is Smad2/3- and ERK1/2-dependent and influences cell adhesion. Am J Transl Res 8(5):2394–2402\nRoberts M, Luo X, Chegini N (2005) Differential regulation of interleukins IL-13 and IL-15 by ovarian steroids, TNF-alpha and TGF-beta in human endometrial epithelial and stromal cells. Mol Hum Reprod 11(10):751–760. https://doi.org/10.1093/molehr/gah233\nChang KK, Liu LB, Li H et al (2014) TSLP induced by estrogen stimulates secretion of MCP-1 and IL-8 and growth of human endometrial stromal cells through JNK and NF-κB signal pathways. Int J Clin Exp Pathol 7(5):1889–1899\nYang HL, Chang KK, Mei J et al (2018) Estrogen restricts the apoptosis of endometrial stromal cells by promoting TSLP secretion. Mol Med Rep 18(5):4410–4416. https://doi.org/10.3892/mmr.2018.9428\nGargett CE (2006) Identification and characterisation of human endometrial stem/progenitor cells. Aust N Z J Obstet Gynaecol 46(3):250–253. https://doi.org/10.1111/j.1479-828X.2006.00582.x\nGargett CE, Schwab KE, Zillwood RM et al (2009) Isolation and culture of epithelial progenitors and mesenchymal stem cells from human endometrium. Biol Reprod 80(6):1136–1145. https://doi.org/10.1095/biolreprod.108.075226\nNikoo S, Ebtekar M, Jeddi-Tehrani M et al (2014) Menstrual blood-derived stromal stem cells from women with and without endometriosis reveal different phenotypic and functional characteristics. Mol Hum Reprod 20(9):905–918. https://doi.org/10.1093/molehr/gau044\nGargett CE, Masuda H (2010) Adult stem cells in the endometrium. Mol Hum Reprod 16(11):818–834. https://doi.org/10.1093/molehr/gaq061\nKao AP, Wang KH, Chang CC et al (2011) Comparative study of human eutopic and ectopic endometrial mesenchymal stem cells and the development of an in vivo endometriotic invasion model. Fertil Steril 95(4):1308–1315. https://doi.org/10.1016/j.fertnstert.2010.09.064\nGurung S, Deane JA, Masuda H et al (2015) Stem cells in endometrial physiology. Semin Reprod Med 33(5):326–332. https://doi.org/10.1055/s-0035-1558405\nLi F, Alderman MH 3rd, Tal A et al (2018) Hematogenous dissemination of mesenchymal stem cells from endometriosis. Stem Cells 36(6):881–890. https://doi.org/10.1002/stem.2804\nKoippallil Gopalakrishnan Nair AR, Pandit H, Warty N et al (2015) Endometriotic mesenchymal stem cells exhibit a distinct immune phenotype. Int Immunol 27(4):195–204. https://doi.org/10.1093/intimm/dxu103\nLi J, Dai Y, Zhu H et al (2016) Endometriotic mesenchymal stem cells significantly promote fibrogenesis in ovarian endometrioma through the Wnt/β-catenin pathway by paracrine production of TGF-β1 and Wnt1. Hum Reprod 31(6):1224–1235. https://doi.org/10.1093/humrep/dew058\nKokoroishi K, Nakashima A, Doi S et al (2016) High glucose promotes TGF-β1 production by inducing FOS expression in human peritoneal mesothelial cells. Clin Exp Nephrol 20(1):30–38. https://doi.org/10.1007/s10157-015-1128-9\nYoung VJ, Ahmad SF, Duncan WC et al (2017) The role of TGF-β in the pathophysiology of peritoneal endometriosis. Hum Reprod Update 23(5):548–559. https://doi.org/10.1093/humupd/dmx016\nOmwandho CO, Konrad L, Halis G et al (2010) Role of TGF-betas in normal human endometrium and endometriosis. Hum Reprod 25(1):101–109. https://doi.org/10.1093/humrep/dep382\nBrosens IA (1997) Endometriosis–a disease because it is characterized by bleeding. Am J Obstet Gynecol 176(2):263–267\nDing D, Liu X, Duan J et al (2015) Platelets are an unindicted culprit in the development of endometriosis: clinical and experimental evidence. Hum Reprod 30(4):812–832. https://doi.org/10.1093/humrep/dev025\nGuo SW, Ding D, Geng JG et al (2015) P-selectin as a potential therapeutic target for endometriosis. Fertil Steril 103(4):990–1000. https://doi.org/10.1016/j.fertnstert.2015.01.001\nZhang Q, Ding D, Liu X et al (2015) Activated platelets induce estrogen receptor β expression in endometriotic stromal cells. Gynecol Obstet Investig 80(3):187–192. https://doi.org/10.1159/000377629\nSmyth SS, McEver RP, Weyrich AS et al (2009) Platelet colloquium participants. Platelet functions beyond hemostasis. J Thromb Haemost 7(11):1759–1766. https://doi.org/10.1111/j.1538-7836.2009.03586.x\nWu Q, Ding D, Liu X et al (2015) Evidence for a hypercoagulable state in women with ovarian endometriomas. Reprod Sci 22(9):1107–1114. https://doi.org/10.1177/1933719115572478\nLi XJ, Zhou M, Li XH et al (2009) Effects of Tanshinone IIa on cytokines and platelets in immune vasculitis and its mechanism. Zhongguo Shi Yan Xue Ye Xue Za Zhi 17(1):188–192\nShang Q, Xu H, Huang L (2012) Tanshinone IIA: a promising natural cardioprotective agent. Evid Based Complement Alternat Med 2012:716459. https://doi.org/10.1155/2012/716459\nZhang Q, Liu X, Guo SW (2017) Progressive development of endometriosis and its hindrance by anti-platelet treatment in mice with induced endometriosis. Reprod Biomed Online 34(2):124–136. https://doi.org/10.1016/j.rbmo.2016.11.006\nGuo SW, Du Y, Liu X (2016) Endometriosis-derived stromal cells secrete thrombin and thromboxane A2, inducing platelet activation. Reprod Sci 23(8):1044–1052. https://doi.org/10.1177/1933719116630428\nGuo SW, Du Y, Liu X (2016) Platelet-derived TGF-β1 mediates the down-modulation of NKG2D expression and may be responsible for impaired natural killer (NK) cytotoxicity in women with endometriosis. Hum Reprod 31(7):1462–1474. https://doi.org/10.1093/humrep/dew057\nDu Y, Liu X, Guo SW (2017) Platelets impair natural killer cell reactivity and function in endometriosis through multiple mechanisms. Hum Reprod 32(4):794–810. https://doi.org/10.1093/humrep/dex014\nLiu XT, Sun HT, Zhang ZF et al (2018) Indoleamine 2,3-dioxygenase suppresses the cytotoxicity of NK cells in response to ectopic endometrial stromal cells in endometriosis. Reproduction 156(5):397–404. https://doi.org/10.1530/REP-18-0112\nJovanovic I, Radosavljevic G, Mitrovic M et al (2011) ST2 deletion enhances innate and acquired immunity to murine mammary carcinoma. Eur J Immunol 1(7):1902–1912. https://doi.org/10.1002/eji.201141417\nMancini F, Milardi D, Carfagna P et al (2018) Low-dose SKA Progesterone and Interleukin-10 modulate the inflammatory pathway in endometriotic cell lines. Int Immunopharmacol 55:223–230. https://doi.org/10.1016/j.intimp.2017.12.008\nJiang J, Yu K, Jiang Z et al (2018) IL-37 affects the occurrence and development of endometriosis by regulating the biological behavior of endometrial stromal cells through multiple signaling pathways. Biol Chem 399(11):1325–1337. https://doi.org/10.1515/hsz-2018-0254\nYang WV, Au HK, Chang CW et al (2005) Matrix remodeling and endometriosis. Reprod Med Biol 4(2):93–99. https://doi.org/10.1111/j.1447-0578.2005.00098.x\nUlukus M, Cakmak H, Arici A (2006) The role of endometrium in endometriosis. J Soc Gynecol Investig 13(7):467–476. https://doi.org/10.1016/j.jsgi.2006.07.005\nSzymanowski K (2007) Apoptosis pattern in human endometrium in women with pelvic endometriosis. Eur J Obstet Gynecol Reprod Biol 132(1):107–110. https://doi.org/10.1016/j.ejogrb.2006.04.008\nLi MQ, Luo XZ, Meng YH et al (2012) CXCL8 enhances proliferation and growth and reduces apoptosis in endometrial stromal cells in an autocrine manner via a CXCR1-triggered PTEN/AKT signal pathway. Hum Reprod 27(7):2107–2116. https://doi.org/10.1093/humrep/des132\nLi MQ, Shao J, Meng YH et al (2013) NME1 suppression promotes growth, adhesion and implantation of endometrial stromal cells via Akt and MAPK/Erk1/2 signal pathways in the endometriotic milieu. Hum Reprod 28(10):2822–2831. https://doi.org/10.1093/humrep/det248\nLi X, Zhang Y, Zhao L et al (2014) Whole-exome sequencing of endometriosis identifies frequent alterations in genes involved in cell adhesion and chromatin-remodeling complexes. Hum Mol Genet 23(22):6008–6021. https://doi.org/10.1093/hmg/ddu330\nMei J, Zhu XY, Jin LP et al (2015) Estrogen promotes the survival of human secretory phase endometrial stromal cells via CXCL12/CXCR4 up-regulation-mediated autophagy inhibition. Hum Reprod 30(7):1677–1689. https://doi.org/10.1093/humrep/dev100\nYang HL, Mei J, Chang KK et al (2017) Autophagy in endometriosis. Am J Transl Res 9(11):4707–4725\nOuYang Z, Hirota Y, Osuga Y et al (2008) Interleukin-4 stimulates proliferation of endometriotic stromal cells. Am J Pathol 173(2):463–469. https://doi.org/10.2353/ajpath.2008.071044\nQuattrone F, Sanchez AM, Pannese M et al (2015) The targeted delivery of interleukin 4 inhibits development of endometriotic lesions in a mouse model. Reprod Sci 22(9):1143–1152. https://doi.org/10.1177/1933719115578930\nSchwager K, Bootz F, Imesch P et al (2011) The antibody-mediated targeted delivery of interleukin-10 inhibits endometriosis in a syngeneic mouse model. Hum Reprod 26(9):2344–2352. https://doi.org/10.1093/humrep/der195\nLiu Q, Ma P, Liu L et al (2017) Evaluation of PLGA containing anti-CTLA4 inhibited endometriosis progression by regulating CD4+CD25+ Treg cells in peritoneal fluid of mouse endometriosis model. Eur J Pharm Sci 96:542–550. https://doi.org/10.1016/j.ejps.2016.10.031\nChegini N (2008) TGF-beta system: the principal profibrotic mediator of peritoneal adhesion formation. Semin Reprod Med 26(4):298–312. https://doi.org/10.1055/s-0028-1082388\nBristol-Gould SK, Hutten CG, Sturgis C et al (2005) The development of a mouse model of ovarian endosalpingiosis. Endocrinology 146(12):5228–5236. https://doi.org/10.1210/en.2005-0697\nCorrea LF, Zheng Y, Delaney AA et al (2016) TGF-β induces endometriotic progression via a noncanonical, KLF11-mediated mechanism. Endocrinology 157(9):3332–3343. https://doi.org/10.1210/en.2016-1194\nLin X, Dai Y, Xu W et al (2018) Hypoxia promotes ectopic adhesion ability of endometrial stromal cells via TGF-β1/Smad signaling in endometriosis. Endocrinology 159(4):1630–1641. https://doi.org/10.1210/en.2017-03227\nTani H, Sato Y, Ueda M et al (2016) Role of versican in the pathogenesis of peritoneal endometriosis. J Clin Endocrinol Metab 101(11):4349–4356. https://doi.org/10.1210/jc.2016-2391\nAu HK, Chang JH, Wu YC et al (2015) TGF-βI regulates cell migration through pluripotent transcription factor OCT4 in endometriosis. PLoS One 10(12):e0145256. https://doi.org/10.1371/journal.pone.0145256\nZhang Q, Duan J, Liu X et al (2016) Platelets drive smooth muscle metaplasia and fibrogenesis in endometriosis through epithelial-mesenchymal transition and fibroblast-to-myofibroblast transdifferentiation. Mol Cell Endocrinol 428:1–16. https://doi.org/10.1016/j.mce.2016.03.015\nLiu YG, Tekmal RR, Binkley PA et al (2009) Induction of endometrial epithelial cell invasion and c-fms expression by transforming growth factor beta. Mol Hum Reprod 15(10):665–673. https://doi.org/10.1093/molehr/gap043\nStocks MM, Crispens MA, Ding T et al (2017) Therapeutically targeting the inflammasome product in a chimeric model of endometriosis-related surgical adhesions. Reprod Sci 24(8):1121–1128. https://doi.org/10.1177/1933719117698584\nYang YM, Yang WX (2017) Epithelial-to-mesenchymal transition in the development of endometriosis. Oncotarget 8(25):41679–41689. https://doi.org/10.18632/oncotarget.16472\nBilyk O, Coatham M, Jewer M et al (2017) Epithelial-to-mesenchymal transition in the female reproductive tract: from normal functioning to disease pathology. Front Oncol 7:145. https://doi.org/10.3389/fonc.2017.00145\nMatsuzaki S, Darcha C, Pouly JL et al (2017) Effects of matrix stiffness on epithelial to mesenchymal transition-like processes of endometrial epithelial cells: implications for the pathogenesis of endometriosis. Sci Rep 7:44616. https://doi.org/10.1038/srep44616\nMatsuzaki S, Darcha C (2014) Antifibrotic properties of epigallocatechin-3-gallate in endometriosis. Hum Reprod 29(8):1677–1687. https://doi.org/10.1093/humrep/deu123\nMatsuzaki S, Canis M, Pouly JL et al (2016) Soft matrices inhibit cell proliferation and inactivate the fibrotic phenotype of deep endometriotic stromal cells in vitro. Hum Reprod 31(3):541–553. https://doi.org/10.1093/humrep/dev333\nZeng X, Yue Z, Gao Y et al (2018) NR4A1 is involved in fibrogenesis in ovarian endometriosis. Cell Physiol Biochem 46(3):1078–1090. https://doi.org/10.1159/000488838\nItoga T, Matsumoto T, Takeuchi H et al (2003) Fibrosis and smooth muscle metaplasia in rectovaginal endometriosis. Pathol Int 53:371–375\nSandoval P, Jiménez-Heffernan JA, Guerra-Azcona G et al (2016) Mesothelial-to-mesenchymal transition in the pathogenesis of post-surgical peritoneal adhesions. J Pathol 239(1):48–59. https://doi.org/10.1002/path.4695\nJi X, Li J, Xu L et al (2013) IL4 and IL-17A provide a Th2/Th17-polarized inflammatory milieu in favor of TGF-β1 to induce bronchial epithelial-mesenchymal transition (EMT). Int J Clin Exp Pathol 6(8):1481–1492\nLiu CY, Xu JY, Shi XY et al (2013) M2-polarized tumor-associated macrophages promoted epithelial-mesenchymal transition in pancreatic cancer cells, partially through TLR4/IL-10 signaling pathway. Lab Investig 93(7):844–854. https://doi.org/10.1038/labinvest.2013.69\nCao H, Zhang J, Liu H et al (2016) IL-13/STAT6 signaling plays a critical role in the epithelial-mesenchymal transition of colorectal cancer cells. Oncotarget 7(38):61183–61198. https://doi.org/10.18632/oncotarget.11282\nXu Z, Zhao C, Wang Z et al (2018) Interleukin-33 levels are elevated in chronic allograft dysfunction of kidney transplant recipients and promotes epithelial to mesenchymal transition of human kidney (HK-2) cells. Gene 644:113–121. https://doi.org/10.1016/j.gene.2017.11.010\nJiang M, Wang Y, Zhang H et al (2018) IL-37 inhibits invasion and metastasis in non-small cell lung cancer by suppressing the IL-6/STAT3 signaling pathway. Thorac Cancer 9(5):621–629. https://doi.org/10.1111/1759-7714.12628\nWang T, Liu Y, Zou JF et al (2017) Interleukin-17 induces human alveolar epithelial to mesenchymal cell transition via the TGF-β1 mediated Smad2/3 and ERK1/2 activation. PLoS One 12(9):e0183972. https://doi.org/10.1371/journal.pone.0183972\nWeng SY, Wang X, Vijayan S et al (2018) IL-4 receptor alpha signaling through macrophages differentially regulates liver fibrosis progression and reversal. EBioMedicine 29:92–103. https://doi.org/10.1016/j.ebiom.2018.01.028\nSantulli P, Even M, Chouzenoux S et al (2013) Profibrotic interleukin-33 is correlated with uterine leiomyoma tumour burden. Hum Reprod 28(8):2126–2133. https://doi.org/10.1093/humrep/det238\nTang J, Huang H, Ji X et al (2014) Involvement of IL-13 and tissue transglutaminase in liver granuloma and fibrosis after Schistosoma japonicum infection. Mediat Inflamm 2014:753483. https://doi.org/10.1155/2014/753483\nZhang LJ, Zheng WD, Chen YX et al (2007) Antifibrotic effects of interleukin-10 on experimental hepatic fibrosis. Hepatogastroenterology 54(79):2092–2098\nDjokovic D, Calhaz-Jorge C (2014) Angiogenesis as a therapeutic target in endometriosis. Acta Med Port 27(4):489–497\nMarí-Alexandre J, García-Oms J, Barceló-Molina M et al (2015) MicroRNAs and angiogenesis in endometriosis. Thromb Res 135(Suppl 1):S38–S40. https://doi.org/10.1016/S0049-3848(15)50439-8\nSalcedo R, Young HA, Ponce ML et al (2001) Eotaxin (CCL11) induces in vivo angiogenic responses by human CCR3+ endothelial cells. J Immunol 166(12):7571–7578\nNa YJ, Yang SH, Baek DW et al (2006) Effects of peritoneal fluid from endometriosis patients on the release of vascular endothelial growth factor by neutrophils and monocytes. Hum Reprod 21(7):1846–1855. https://doi.org/10.1093/humrep/del077\nYoung VJ, Ahmad SF, Brown JK et al (2015) Peritoneal VEGF-A expression is regulated by TGF-β1 through an ID1 pathway in women with endometriosis. Sci Rep 5:16859. https://doi.org/10.1038/srep16859\nFujimoto J, Sakaguchi H, Aoki I et al (2000) Clinical implications of expression of interleukin-8 related to angiogenesis in uterine cervical cancers. Cancer Res 60:2632–2635\nXie F, Meng YH, Liu LB et al (2013) Cervical carcinoma cells stimulate the angiogenesis through TSLP promoting growth and activation of vascular endothelial cells. Am J Reprod Immunol 70(1):69–79. https://doi.org/10.1111/aji.12104\nBulun SE (2009) Endometriosis. N Engl J Med 360(3):268–279. https://doi.org/10.1056/NEJMra0804690\nUrata Y, Osuga Y, Akiyama I et al (2013) Interleukin-4 and prostaglandin E2 synergistically up-regulate 3β-hydroxysteroid dehydrogenase type 2 in endometrioma stromal cells. J Clin Endocrinol Metab 98(4):1583–1590. https://doi.org/10.1210/jc.2012-3475\nWang Y, Yu J, Luo X et al (2010) Abnormal regulation of chemokine TECK and its receptor CCR9 in the endometriotic milieu is involved in pathogenesis of endometriosis by way of enhancing invasiveness of endometrial stromal cells. Cell Mol Immunol 7(1):51–60. https://doi.org/10.1038/cmi.2009.102\nReis FM, Petraglia F, Taylor RN (2013) Endometriosis: hormone regulation and clinical consequences of chemotaxis and apoptosis. Hum Reprod Update 19(4):406–418. https://doi.org/10.1093/humupd/dmt010\nBorrelli GM, Carvalho KI, Kallas EG et al (2013) Chemokines in the pathogenesis of endometriosis and infertility. J Reprod Immunol 98(1–2):1–9. https://doi.org/10.1016/j.jri.2013.03.003\nBorrelli GM, Abrão MS, Mechsner S (2014) Can chemokines be used as biomarkers for endometriosis? A systematic review. Hum Reprod 29(2):253–266. https://doi.org/10.1093/humrep/det401\nWu RF, Yang HM, Zhou WD et al (2017) Effect of interleukin-1β and lipoxin A4 in human endometriotic stromal cells: proteomic analysis. J Obstet Gynaecol Res 43(2):308–319. https://doi.org/10.1111/jog.13201\nMei J, Zhou WJ, Zhu XY et al (2018) Suppression of autophagy and HCK signaling promotes PTGS2high FCGR3- NK cell differentiation triggered by ectopic endometrial stromal cells. Autophagy 14(8):1376–1397. https://doi.org/10.1080/15548627.2018.1476809\nGiudice LC (2010) Clinical practice. Endometriosis. N Engl J Med 362(25):2389–2398. https://doi.org/10.1056/NEJMcp1000274\nZheng W, Flavell RA (1997) The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 89(4):587–596\nFarrar JD, Asnagli H, Murphy KM (2002) T helper subset development: roles of instruction, selection, and transcription. J Clin Investig 109(4):431–435. https://doi.org/10.1172/JCI15093\nChen P, Wang DB, Liang YM (2016) Evaluation of estrogen in endometriosis patients: regulation of GATA-3 in endometrial cells and effects on Th2 cytokines. J Obstet Gynaecol Res 42(6):669–677. https://doi.org/10.1111/jog.12957\nSaia RS, Bertozi G, Cunha FQ et al (2011) Estradiol and thermoregulation in adult endotoxemic rats exposed to lipopolysaccharide in neonatal life. Acta Physiol (Oxf) 203(4):429–439. https://doi.org/10.1111/j.1748-1716.2011.02334.x\nZhang Y, Jin LP (2017) Effects of TSLP on obstetrical and gynecological diseases. Am J Reprod Immunol. https://doi.org/10.1111/aji.12612\nWang G, Tokushige N, Russell P et al (2010) Neuroendocrine cells in eutopic endometrium of women with endometriosis. Hum Reprod 25(2):387–391. https://doi.org/10.1093/humrep/dep379\nKempuraj D, Papadopoulou N, Stanford EJ et al (2004) Increased numbers of activated mast cells in endometriosis lesions positive for corticotropin-releasing hormone and urocortin. Am J Reprod Immunol 52(4):267–275. https://doi.org/10.1111/j.1600-0897.2004.00224.x\nFlorio P, Reis FM, Torres PB et al (2007) Plasma urocortin levels in the diagnosis of ovarian endometriosis. Obstet Gynecol 110(3):594–600. https://doi.org/10.1097/01.AOG.0000278572.86019.ae\nNovembri R, Borges LE, Carrarelli P et al (2011) Impaired CRH and urocortin expression and function in eutopic endometrium of women with endometriosis. J Clin Endocrinol Metab 96(4):1145–1150. https://doi.org/10.1210/jc.2010-2263\nNovembri R, Carrarelli P, Toti P et al (2011) Urocortin 2 and urocortin 3 in endometriosis: evidence for a possible role in inflammatory response. Mol Hum Reprod 17(9):587–593. https://doi.org/10.1093/molehr/gar020\nSomigliana E, Vigano P, Barbara G et al (2009) Treatment of endometriosis-related pain: options and outcomes. Front Biosci (Elite Ed) 1:455–465\nFerrero S, Alessandri F, Racca A et al (2015) Treatment of pain associated with deep endometriosis: alternatives and evidence. Fertil Steril 104(4):771–792. https://doi.org/10.1016/j.fertnstert.2015.08.031\nTosti C, Biscione A, Morgante G et al (2017) Hormonal therapy for endometriosis: from molecular research to bedside. Eur J Obstet Gynecol Reprod Biol 209:61–66. https://doi.org/10.1016/j.ejogrb.2016.05.032\nAngioni S, Pontis A, Dessole M et al (2015) Pain control and quality of life after laparoscopic en-block resection of deep infiltrating endometriosis (DIE) vs. incomplete surgical treatment with or without GnRHa administration after surgery. Arch Gynecol Obstet 291(2):363–370. https://doi.org/10.1007/s00404-014-3411-5\nVelasco I, Campos A, Acién P (2005) Changes in cytokine levels of patients with ovarian endometriosis after treatment with gonadotropin-releasing hormone analogue, ultrasound-guided drainage, and intracystic recombinant interleukin-2. Fertil Steril 83(4):873–877. https://doi.org/10.1016/j.fertnstert.2004.10.035\nSelak V, Farquhar C, Prentice A et al (2007) Danazol for pelvic pain associated with endometriosis. Cochrane Database Syst Rev 4:CD000068. https://doi.org/10.1002/14651858.CD000068.pub2\nUchiyama M, Jin X, Zhang Q et al (2012) Induction of regulatory CD4+ cells and prolongation of survival of fully allogeneic murine cardiac grafts by danazol. Transplant Proc 44(4):1067–1069. https://doi.org/10.1016/j.transproceed.2012.01.103\nUchiyama M, Jin X, Zhang Q et al (2012) Danazol induces prolonged survival of fully allogeneic cardiac grafts and maintains the generation of regulatory CD4(+) cells in mice. Transpl Int 25(3):357–365. https://doi.org/10.1111/j.1432-2277.2011.01427.x\nUmezawa M, Tanaka N, Takeda K et al (2011) Clarithromycin and telithromycin increases interleukin-10 expression in the rat endometriosis model. Cytokine 55(3):339–342. https://doi.org/10.1016/j.cyto.2011.05.014\nMaione F, De Feo V, Caiazzo E et al (2014) Tanshinone IIA, a major component of Salvia milthorriza Bunge, inhibits platelet activation via Erk-2 signaling pathway. J Ethnopharmacol 155(2):1236–1242. https://doi.org/10.1016/j.jep.2014.07.010\nJiang X, Chen Y, Zhu H et al (2015) Sodium Tanshinone IIA sulfonate ameliorates bladder fibrosis in a rat model of partial bladder outlet obstruction by inhibiting the TGF-β/Smad pathway activation. PLoS One 10(6):e0129655. https://doi.org/10.1371/journal.pone.0129655\nTang H, He H, Ji H et al (2015) Tanshinone IIA ameliorates bleomycin-induced pulmonary fibrosis and inhibits transforming growth factor-beta-β-dependent epithelial to mesenchymal transition. J Surg Res 197(1):167–175. https://doi.org/10.1016/j.jss.2015.02.062\nChristensen LP (2009) Ginsenosides chemistry, biosynthesis, analysis, and potential health effects. Adv Food Nutr Res 55:1–99. https://doi.org/10.1016/S1043-4526(08)00401-4\nWong AS, Che CM, Leung KW (2015) Recent advances in ginseng as cancer therapeutics: a functional and mechanistic overview. Nat Prod Rep 32(2):256–272. https://doi.org/10.1039/c4np00080c\nXu FY, Shang WQ, Yu JJ et al (2016) The antitumor activity study of ginsenosides and metabolites in lung cancer cell. Am J Transl Res 8(4):1708–1718\nGu CJ, Cheng J, Zhang B et al (2017) Protopanaxadiol and metformin synergistically inhibit estrogen-mediated proliferation and anti-autophagy effects in endometrial cancer cells. Am J Transl Res 9(9):4071–4082\nKim MK, Lee SK, Park JH et al (2017) Ginsenoside Rg3 decreases fibrotic and invasive nature of endometriosis by modulating miRNA-27b: in vitro and in vivo studies. Sci Rep 7(1):17670. https://doi.org/10.1038/s41598-017-17956-0\nZhang B, Zhou WJ, Gu CJ et al (2018) The ginsenoside PPD exerts anti-endometriosis effects by suppressing estrogen receptor-mediated inhibition of endometrial stromal cell autophagy and NK cell cytotoxicity. Cell Death Dis 9(5):574. https://doi.org/10.1038/s41419-018-0581-2\nCao Y, Ye Q, Zhuang M et al (2017) Ginsenoside Rg3 inhibits angiogenesis in a rat model of endometriosis through the VEGFR-2-mediated PI3K/Akt/mTOR signaling pathway. PLoS One 12(11):e0186520. https://doi.org/10.1371/journal.pone.0186520\nQin X, Liu Y, Feng Y et al (2018) Ginsenoside Rf alleviates dysmenorrhea and inflammation through the BDNF-TrkB-CREB pathway in a rat model of endometriosis. Food Funct. https://doi.org/10.1039/c8fo01839a\nLaschke MW, Schwender C, Scheuer C et al (2008) Epigallocatechin-3-gallate inhibits estrogen-induced activation of endometrial cells in vitro and causes regression of endometriotic lesions in vivo. Hum Reprod 23(10):2308–2318. https://doi.org/10.1093/humrep/den245\nXu H, Lui WT, Chu CY et al (2009) Anti-angiogenic effects of green tea catechin on an experimental endometriosis mouse model. Hum Reprod 24(3):608–618. https://doi.org/10.1093/humrep/den417\nXu H, Becker CM, Lui WT et al (2011) Green tea epigallocatechin-3-gallate inhibits angiogenesis and suppresses vascular endothelial growth factor C/vascular endothelial growth factor receptor 2 expression and signaling in experimental endometriosis in vivo. Fertil Steril 96(4):1021–1028. https://doi.org/10.1016/j.fertnstert.2011.07.008\nWang CC, Xu H, Man GC et al (2013) Prodrug of green tea epigallocatechin-3-gallate (Pro-EGCG) as a potent anti-angiogenesis agent for endometriosis in mice. Angiogenesis 16(1):59–69. https://doi.org/10.1007/s10456-012-9299-4\nCarvalho LF, Samadder AN, Agarwal A et al (2012) Oxidative stress biomarkers in patients with endometriosis: systematic review. Arch Gynecol Obstet 286(4):1033–1040. https://doi.org/10.1007/s00404-012-2439-7\nRocha MG, Gomes VA, Tanus-Santos JE et al (2015) Reduction of blood nitric oxide levels is associated with clinical improvement of the chronic pelvic pain related to endometriosis. Braz J Med Biol Res 48(4):363–369. https://doi.org/10.1590/1414-431X20143619\nChang RH, Feng MH, Liu WH et al (1997) Nitric oxide increased interleukin-4 expression in T lymphocytes. Immunology 90(3):364–369\nMier-Cabrera J, González-Gallardo S, Hernández-Guerrero C (2013) Effect of nitric oxide and TH1/TH2 cytokine supplementation over ectopic endometrial tissue growth in a murine model of endometriosis. Reprod Sci 20(11):1332–1338. https://doi.org/10.1177/1933719113485297\nMei J, Li MQ, Ding D et al (2013) Indoleamine 2,3-dioxygenase-1 (IDO1) enhances survival and invasiveness of endometrial stromal cells via the activation of JNK signaling pathway. Int J Clin Exp Pathol 6(3):431–444\nMei J, Chang KK, Sun HX (2017) Immunosuppressive macrophages induced by IDO1 promote the growth of endometrial stromal cells in endometriosis. Mol Med Rep 15(4):2255–2260. https://doi.org/10.3892/mmr.2017.6242\nWeigert C, Brodbeck K, Sawadogo M et al (2004) Upstream stimulatory factor (USF) proteins induce human TGF-beta1 gene activation via the glucose-response element-1013/-1002 in mesangial cells: up-regulation of USF activity by the hexosamine biosynthetic pathway. J Biol Chem 279(16):15908–15915. https://doi.org/10.1074/jbc.M313524200\nSinaii N, Clearly SD, Ballweg ML et al (2002) High rates of autoimmune and endocrine disorders, fibromyalgia, chronic fatigue syndrome and atopic diseases among women with endometriosis: a survey analysis. Hum Reprod 17(10):2715–2724\nWang CT, Wang DB, Liu KR et al (2015) Inducing malignant transformation of endometriosis in rats by long-term sustaining hyperestrogenemia and type II diabetes. Cancer Sci 106(1):43–50. https://doi.org/10.1111/cas.12573\nSerhan CN (2005) Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution. Prostaglandins Leukot Essent Fatty Acids 73(3–4):141–162. https://doi.org/10.1016/j.plefa.2005.05.002\nMitchell S, Thomas G, Harvey K et al (2002) Lipoxins, aspirin-triggered epi-lipoxins, lipoxin stable analogues, and the resolution of inflammation: stimulation of macrophage phagocytosis of apoptotic neutrophils in vivo. J Am Soc Nephrol 13(10):2497–2507\nKumar R, Clerc AC, Gori I et al (2014) Lipoxin A4 prevents the progression of de novo and established endometriosis in a mouse model by attenuating prostaglandin E2 production and estrogen signaling. PLoS One 9(2):e89742. https://doi.org/10.1371/journal.pone.0089742\nKyama CM, Overbergh L, Mihalyi A et al (2008) Effect of recombinant human TNF-binding protein-1 and GnRH antagonist on mRNA expression of inflammatory cytokines and adhesion and growth factors in endometrium and endometriosis tissues in baboons. Fertil Steril 89(5 Suppl):1306–1313. https://doi.org/10.1016/j.fertnstert.2006.11.205\nDaftary GS, Zheng Y, Tabbaa ZM et al (2013) A novel role of the Sp/KLF transcription factor KLF11 in arresting progression of endometriosis. PLoS One 8(3):e60165. https://doi.org/10.1371/journal.pone.0060165\nFalconer H, Mwenda JM, Chai DC et al (2008) Effects of anti-TNF-mAb treatment on pregnancy in baboons with induced endometriosis. Fertil Steril 89(5 Suppl):1537–1545. https://doi.org/10.1016/j.fertnstert.2007.05.062\nAcknowledgements\nThis work was supported by the National Natural Science Foundation of China (NSFC) (nos. 91542108, 81471513, 31671200, 81601354, 31600735 and 81571509), the Shanghai Rising-Star Program (no. 16QA1400800), the Innovation-oriented Science and Technology Grant from NPFPC Key Laboratory of Reproduction Regulation (CX2017-2), the Program for Zhuoxue of Fudan University, the National Science Foundation of Jiangsu Province (no. BK20160128), the Fundamental Research Funds for the Central Universities (no. 021414380180), the Open Project Program of Shanghai Key Laboratory of Female Reproductive Endocrine-Related Diseases (CN) (no. 14DZ2271700).\nAuthor information\nAuthors and Affiliations\nContributions\nMQL designed and wrote the review, and supervised and critically reviewed the complete manuscript. WJZ and HLY performed the literature search, drafted the manuscript and prepared the figures. JS, KKC and JM helped to perform revisions and critically discussed the completed manuscript.\nCorresponding author\nEthics declarations\nConflict of interest\nThe authors declare that the research was conducted in the absence of any commercial or financial relationships that could be considered as potential conflicts of interest.\nAdditional information\nPublisher's Note\nSpringer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.\nRights and permissions\nAbout this article\nCite this article\nZhou, WJ., Yang, HL., Shao, J. et al. Anti-inflammatory cytokines in endometriosis. Cell. Mol. Life Sci. 76, 2111–2132 (2019). https://doi.org/10.1007/s00018-019-03056-x\nReceived:\nRevised:\nAccepted:\nPublished:\nVersion of record:\nIssue date:\nDOI: https://doi.org/10.1007/s00018-019-03056-x","source_license":"CC0","license_restricted":false}